DONGWHA PHARM, the first established pharmaceutical company in Korea founded in 1897, has been engaged in development, production, distribution and marketing of ethical drugs including solid dosage formulations and sterile injectables, APIs, over-the-counter drugs, food supplements, healthcare products, and cosmetics. With a goal to become a global hub for drug development, DONGWHA PHARM has been contributing to human health and well-being worldwide through innovative drug discovery, and global commercialization, driven by the state-of-the-art facilities and the research center. DONGWHA Research Institute has provided the foundation for development of high quality medicines and innovative NCE, such as Zabofloxacin.Number of Partnerships: 10
